Prospective study of the clinical outcome of immediate and maintenance treatment of deep leg and pelvic vein thrombosis for various risk factors

• Conditions: I80.20; I80.28

• Registration Number: DRKS00018104
• Lead Sponsor: Hämophiliezentrum, Institut für Transfusionsmedizin, Medizinische Klinik III, Goethe Universitätsklinikum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-10
• Study Completion: 2020-12-31
• Results First Posted: 2023-04-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

patients with deep leg and pelvic vein thrombosis (diagnosis since July 2018)
- patients with rezidiv
- signed consent form

Exclusion Criteria

- no signed consent form
- patients, whose reduced general condition does not seem to make maintenance therapy after 3 months reasonable

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Outcome: time period until occurence of combined negative event: spread of TVT, embolism, rezidiv, thrombosis, bleeding event, morbidity, mortality